C07K 2319/91
Containing a motif for glycosylation
Official title: containing a motif for glycosylation
C07K2319/91 (Containing a motif for glycosylation) appears on 122 US grants and 185 published applications in this corpus.
Search patents in C07K- Granted patents
- 122
- Published applications
- 185
- Assignees
- 124
- Inventors
- 400
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 1 |
| 2003 | 1 | 5 |
| 2004 | 0 | 1 |
| 2005 | 2 | 0 |
| 2006 | 1 | 3 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 4 |
| 2011 | 1 | 3 |
| 2012 | 0 | 2 |
| 2013 | 2 | 8 |
| 2014 | 2 | 3 |
| 2015 | 5 | 7 |
| 2016 | 5 | 15 |
| 2017 | 5 | 8 |
| 2018 | 9 | 10 |
| 2019 | 11 | 6 |
| 2020 | 8 | 17 |
| 2021 | 5 | 21 |
| 2022 | 5 | 17 |
| 2023 | 14 | 8 |
| 2024 | 5 | 17 |
| 2025 | 14 | 15 |
| 2026 | 2 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cell penetrating peptides24 Mar 2026US 12,583,889 B2Oxford University Innovation Limited
- Glycosylated comp pilin variants, methods of making and uses thereof17 Mar 2026US 12,577,280 B2Vaxnewmo LLC
- Binding molecules with modified J-chain2 Dec 2025US 12,486,336 B2IGM Biosciences, Inc.
- Modified chimeric antigen receptors and methods of use4 Nov 2025US 12,459,979 B2Kite Pharma, Inc.
- Engineered VEGF variants for retinal neuroprotection, promotion of axon growth and axon regeneration2 Sep 2025US 12,404,312 B2Massachusetts Eye and Ear Infirmary
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Il-22 fc fusion proteins and methods of use1 Oct 2026US 2026/0297150 A1Genentech, Inc.
- Glycosylated neuropeptide derivative including neuropeptide sequence and sugar chain, pharmaceutical composition, intranasal/nasal drop formulation, and use of glycosylated neuropeptide derivative10 Sep 2026US 2026/0265331 A1Tokyo University of Science Foundation
- Engineered furin cleavage sequences for co-expression of multiple genes in mammalian cells20 Aug 2026US 2026/0242821 A1Agency for Science, Technology and Research
- Recombinant immune cell-based cell therapeutic agent for treating cancer via polyclonal expansion of tumor-infiltrating t cell in tumor6 Aug 2026US 2026/0224615 A1Korea Advanced Institute of Science and Technology
Most cited
By later US patents
- Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor164US 5,374,548 AGenentech, Inc. · 1994
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999
- Method for producing influenza hemagglutinin multivalent vaccines using baculovirus139US 5,762,939 AMg-Pmc, LLC · 1998
- Carboxy terminal peptide-extended proteins89US 5,712,122 AWashington University · 1998
- Method for producing influenza hemagglutinin multivalent vaccines54US 6,245,532 B1Protein Sciences Corporation · 2001